Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Cancer chemotherapy and pharmacology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Subbiah%2C+Vivek%22&type=Person&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22
/vufind/Search/Results?lookfor=%22Subbiah%2C+Vivek%22&type=Person&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22
Search /vufind/Search2/Results?lookfor=%22Subbiah%2C+Vivek%22&type=Person&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22
PubPharm (16)
1
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
enthalten in:
Cancer chemotherapy and pharmacology
| 2023
von
Piha-Paul, S.
|
Tseng, C.
|
Tran, H.
| +13
Wird geladen...
2
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
enthalten in:
Cancer chemotherapy and pharmacology
| 2023
von
Piha-Paul, S.
|
Tseng, C.
|
Tran, H.
| +13
Wird geladen...
3
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
enthalten in:
Cancer chemotherapy and pharmacology
| 2023
von
Piha-Paul, S.
|
Tseng, C.
|
Tran, H.
| +13
Wird geladen...
4
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
enthalten in:
Cancer chemotherapy and pharmacology
| 2023
von
Piha-Paul, S.
|
Tseng, C.
|
Tran, H.
| +13
Wird geladen...
5
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors : an exposure-response analysis
enthalten in:
Cancer chemotherapy and pharmacology
| 2021
von
Fudio, S.
|
Tabernero, J.
|
Subbiah, V.
| +13
Wird geladen...
6
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis
enthalten in:
Cancer chemotherapy and pharmacology
| 2020
von
Fudio, S.
|
Tabernero, J.
|
Subbiah, V.
| +13
Wird geladen...
7
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis
enthalten in:
Cancer chemotherapy and pharmacology
| 2020
von
Fudio, S.
|
Tabernero, J.
|
Subbiah, V.
| +13
Wird geladen...
8
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis
enthalten in:
Cancer chemotherapy and pharmacology
| 2020
von
Fudio, S.
|
Tabernero, J.
|
Subbiah, V.
| +13
Wird geladen...
9
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement
enthalten in:
Cancer chemotherapy and pharmacology
| 2018
von
Fountzilas, E.
|
Krishnan, E.
|
Janku, F.
| +8
Wird geladen...
10
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement
enthalten in:
Cancer chemotherapy and pharmacology
| 2018
von
Fountzilas, E.
|
Krishnan, E.
|
Janku, F.
| +8
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Cancer chemotherapy and pharmacology
Medienart
16
Aufsätze
12
E-Artikel
12
E-Ressourcen
4
Gedruckte Aufsätze
Zeitschriftentitel
Cancer chemotherapy and pharmacology
Thema
4
Advanced/refractory cancer
4
Bevacizumab
4
Capecitabine
4
Cardiac repolarization
4
Dose-limiting toxicity
4
ECG
4
EGFR
4
ERBB family
4
Effect compartment
4
Hepatic arterial infusion
4
Journal Article
4
KRAS
4
Lurbinectedin
4
Maximum tolerated dose
4
Metformin
4
Neratinib
4
Oxaliplatin
4
Plasma concentration
4
QTcF
4
Temsirolimus
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
8
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
16
Englisch
Haven't found what you're looking for?
Wird geladen...